SALIVARY GLAND CANCER
Clinical trials for SALIVARY GLAND CANCER explained in plain language.
Never miss a new study
Get alerted when new SALIVARY GLAND CANCER trials appear
Sign up with your email to follow new studies for SALIVARY GLAND CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced cancers: immunotherapy drug shows promise in large trial
Disease control OngoingThis study tested the drug pembrolizumab in over 1,600 people with various advanced solid tumors that had stopped responding to standard treatments. The goal was to see if the drug could shrink or control the tumors. The trial focused on identifying which patients were most likel…
Matched conditions: SALIVARY GLAND CANCER
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New combo therapy targets hard-to-treat thyroid and salivary cancers
Disease control OngoingThis phase 2 study tests whether adding the immunotherapy drug pembrolizumab to the chemotherapy drug docetaxel can shrink tumors in people with advanced thyroid or salivary gland cancers that are not responding to standard treatments. About 46 adults with these rare, hard-to-tre…
Matched conditions: SALIVARY GLAND CANCER
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for rare cancer: drug trial targets adenoid cystic carcinoma
Disease control OngoingThis phase 2 study tests the drug amivantamab in 21 people with recurrent or metastatic adenoid cystic carcinoma, a rare salivary gland cancer. The main goal is to see if the drug shrinks tumors or slows disease progression. Participants must have cancer that has worsened recentl…
Matched conditions: SALIVARY GLAND CANCER
Phase: PHASE2 • Sponsor: Trisha Wise-Draper • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug shows promise for rare salivary gland cancer
Disease control OngoingThis study tests a new drug called APG-115, alone or with chemotherapy, in people with a specific type of salivary gland cancer that has a normal p53 gene. The goal is to see if the drug can shrink tumors and to find the safest dose. The trial includes 41 adults whose cancer has …
Matched conditions: SALIVARY GLAND CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
New drug combo shows promise for rare salivary gland cancers
Disease control OngoingThis study tests whether two drugs, lenvatinib and pembrolizumab, can shrink or slow the growth of advanced salivary gland cancers that have spread or come back. About 64 adults with adenoid cystic carcinoma or other salivary gland cancers will take part. The goal is to see how w…
Matched conditions: SALIVARY GLAND CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:41 UTC